APA (7th ed.) Citation

Alipour‐Haris, G., Armstrong, M. J., Okun, M., & Brown, J. D. (2023). Comparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson's Disease Psychosis. Movement Disorders Clinical Practice, 10(3), 406. https://doi.org/10.1002/mdc3.13652

Chicago Style (17th ed.) Citation

Alipour‐Haris, Golnoosh, Melissa J. Armstrong, Michael Okun, and Joshua D. Brown. "Comparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson's Disease Psychosis." Movement Disorders Clinical Practice 10, no. 3 (2023): 406. https://doi.org/10.1002/mdc3.13652.

MLA (9th ed.) Citation

Alipour‐Haris, Golnoosh, et al. "Comparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson's Disease Psychosis." Movement Disorders Clinical Practice, vol. 10, no. 3, 2023, p. 406, https://doi.org/10.1002/mdc3.13652.